Thromb Haemost 1994; 72(06): 973-978
DOI: 10.1055/s-0038-1648992
Original Article
Schattauer GmbH Stuttgart

Effects of Vanadate on Prostacyclin and Endothelin-1 Production and Protein-Tyrosine Phosphorylation in Human Endothelial Cells

Hiromasa Shimizu
1   The First Department of Internal Medicine, Japan
,
Hiroshi Takayama
1   The First Department of Internal Medicine, Japan
,
Jong-Dae Lee
1   The First Department of Internal Medicine, Japan
,
Kazuo Satake
1   The First Department of Internal Medicine, Japan
,
Takanobu Taniguchi
2   Department of Biochemistry, Fukui Medical School, Matsuoka, Fukui, Japan
,
Hirohei Yamamura
2   Department of Biochemistry, Fukui Medical School, Matsuoka, Fukui, Japan
,
Toru Nakamura
1   The First Department of Internal Medicine, Japan
› Author Affiliations
Further Information

Publication History

Received 14 September 1993

Accepted after resubmission 12 July 1994

Publication Date:
06 July 2018 (online)

Summary

The ability of vanadate, an inhibitor of protein-tyrosine phosphatases, to affect the production of prostacyclin (PGI2) and endothelin-1 (ET-1) and protein-tyrosine phosphorylation in human umbilical vein endothelial cells (HUVEC) was studied. The addition of vanadate to monolayers of cultured HUVEC caused a sustained release of PGI2 from HUVEC in a time- and dose-dependent manner. When aspirin-treated HUVEC, which have lost the ability to increase PGI2 production in response to arachidonate, were incubated with vanadate, the cells recovered their ability to increase PGI2 production in response to arachidonate. This recovery of inducible PGI2 production in aspirin-treated HUVEC was completely inhibited either by cycloheximide, a protein synthesis inhibitor, or by actinomycin D, an RNA synthesis inhibitor. In contrast, the same concentration of vanadate suppressed the basal release of ET-1 from HUVEC. Vanadate also caused an increase in protein-tyrosine phosphorylation in HUVEC. These data indicate that vanadate induces opposite effects on PGI2 and ET-1 production with a concomitant increase in protein-tyrosine phosphorylation in HUVEC.

 
  • References

  • 1 Moncada S, Higgs EA, Vane JR. Human arterial and venous tissues generate prostacyclin (prostaglandin X), a potent inhibitor of platelet aggregation. Lancet 1977; 1: 18-20
  • 2 Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415
  • 3 Komuro I, Kurihara H, Sugiyama T, Takaku F, Yazaki Y. Endothelin stimulates c-fos andc-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988; 238: 249-252
  • 4 Egan RW, Paxton J, Kuehl Jr FA. Mechanism for irreversible selfdeactivation of prostaglandin synthetase. J Biol Chem 1976; 251: 7325-7335
  • 5 Hemler ME, Lands WEM. Evidence for a peroxide-initiated free radical mechanism of prostaglandin biosynthesis. J Biol Chem 1980; 255: 6253-6261
  • 6 Roth GJ, Stanford N, Majerus PW. Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci USA 1975; 72: 3073-3076
  • 7 Chen YP, Bienkowski MJ, Mamett LJ. Controlled tryptic digestion ofprostaglandin H synthase. J Biol Chem 1987; 262: 16892-16899
  • 8 Rossi V, Breviario F, Ghezzi P, Dejena E, Mantovani A. Prostacyclin synthesis induced in vascular cells by interleukin-1. Science 1986; 229: 174-176
  • 9 Bailey JM, Muza B, Hla T, Salata K. Restoration of prostacyclin synthase in vascular smooth muscle cells after aspirin treatment: Regulation by epidermal growth factor. J Lipid Res 1985; 26: 54-61
  • 10 Ristimaki A, Ylikovkala O, Viinikka L. Effect of growth factors on human vascular endothelial cell prostacyclin production. Arteriosclerosis 1990; 10: 653-7
  • 11 Wu KK, Hatzakis H, Lo SS, Seong DC, Sanduja SK, Tai HH. Stimulation of de novo synthesis of prostaglandin G/H synthase in human endothelial cells by phorbol ester. J Biol Chem 1988; 263: 19043-19047
  • 12 Yoshizumi M, Kurihara H, Morita T, Yamashita T, Oh-hashi Y, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Yazaki Y. Interleukin-1 increases the production of endothelin-1 by culturedendothelial cells. Biochem Biophys Res Commun 1990; 166: 324-329
  • 13 Kurihara H, Yoshizumi M, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Hamaoki M, Kato H, Yazaki Y. Transforming growth factor-(3 stim-ulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun 1989; 159: 1435-1440
  • 14 Swarup G, Speeg KV, Cohen S, Garbers DL. Phosphotyrosil-protein phosphatase of TCRC-2 cells. J Biol Chem 1982; 257: 7298-7301
  • 15 Brown DJ, Gordon JA. The stimulation of pp60v-scrkinase activity by vanadatein intact cells accompanies a new phosphorylation state of the enzyme. J Biol Chem 1984; 259: 9580-9586
  • 16 Tamura S, Brown TA, Whipple JH, Fujita-Yamaguchi Y, Dubler RE, Cheng K, Lamer J. A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. J Biol Chem 1984; 259: 6650-6658
  • 17 Frost SC, Kobanski RA, Lane DM. Effect of phenylarsine oxide oninsulin-dependent protein phosphorylation and glucose transport in 3T3-L1 adipocytes. J Biol Chem 1987; 262: 9872-9876
  • 18 Torossian K, Freedmann D, Fantus IG. Vanadate down-regulates cell surface insulin and growth hormone receptors and inhibits insulin receptor degradation in cultured human lymphocytes. J Biol Chem 1988; 263: 9353-9359
  • 19 Seglen PO, Gordon PB. Vanadate inhibits protein degradation in isolated rat hepatocytes. J Biol Chem 987 256: 7699-7701
  • 20 Maher PA. Stimulation of endothelial cellproliferation by vanadate is specific for micro vascular endothelial cells. J Cell Physiol 1992; 151: 549-554
  • 21 Lerea KM, Tonks NK, Krebs EG, Fischer EH, Glomset JA. Vanadate and molybdate increasetyrosine phosphorylation in a 50-kilodalton protein and stimulate secretion in electropermeabilized platelets. Biochemistry 1989; 28: 9286-9292
  • 22 Ek B, Heldin C-H. Use of an antiserum against phosphotyrosine for the identificationof phosphorylated components in human fibroblasts stimulated by platelet-derived growth factor. J Biol Chem 1984; 259: 11145-11152
  • 23 Nakamura S, Yamamura H. Thrombin and collagen induce rapid phosphorylation of a common setof cellular proteins on tyrosine inhuman platelets. J Biol Chem 1989; 264: 7089-7091
  • 24 Takayama H, Nakamura T, Yanagi S, Taniguchi T, Nakamura S, Yamamura H. Ionophore A23187-induced protein-tyrosine phosphorylation of humanplatelets: Possible synergism between Ca2+ mobilization and protein kinase C activation. Biochem Biophys Res Commun 1991; 174: 922-927
  • 25 Takayama H, Ezumi Y, Ichinohe T, Okuma M. Involvement of GPIIb-IIIa on human platelets in phosphotyrosine-specific dephosphorylation. Biochem Biophys Res Commun 1993; 194: 472-477
  • 26 Takayama H, Kroll MH, Gimbrone Jr MA, Schafer AI. Turnover of eicosa-noid precursor fatty acids among phospholipid classes and subclasses of cultured human umbilical vein endothelial cells. Biochem J 1989; 258: 427-434
  • 27 Gimbrone Jr MA, Shefton EJ, Cruise SA. Isolation and primary culture of endothelial cells from human umbilical vessels. Tissue Cult Assoc Man 1978; 4: 813-817
  • 28 Taniguchi K, Morimoto S, Fukuo K, Yanagisawa M, Masaki T, Suzuki N, Ogihara T. Interleukin-2 suppresses endothelin-1 secretion of cultured endothelial cells. Hypertens Res 1992; 15: 171-175
  • 29 Kent RS, Diedrich SL, Whorton AR. Regulation of vascular prostaglandin synthesis by metabolites of arachidonic acid in perfused rabbit aorta. J Clin Invest 1983; 72: 455-465
  • 30 Maier JAM, Hla T, Maciag T. Cyclooxygenase is an immediate-early gene induced by interleukin-1in human endothelial cells. J Biol Chem 1990; 265: 10805-10808
  • 31 Endo H, Akahoshi TK, Kashiwazaki S. Additive effects of IL-1 and TNF on prostacyclin synthesis in human vascular cells. Biochem Biophys Res Commun 1988; 156: 1007-1014
  • 32 Cantley LC, Josephson L, Warner R, Yanagisawa M, Lechene C, Guidotti G. Vanadate is a potent (Na, K)-ATPase inhibitor found in ATP derivedfrom muscle. J Biol Chem 1977; 252: 7421-7423
  • 33 Varecka L, Carafoli E. Vanadate-induced movements of Ca2+ and K+ in human red blood cells. J Biol Chem 1982; 257: 7414-7421
  • 34 Fagin JA, Ikejiri K, Levin SR. Insulinotropic effects of vanadate. Diabetes 1987; 36: 1448-1452
  • 35 Hu R-M, Levin ER, Pedram A, Frank HJL. Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes 1993; 42: 351-358
  • 36 Saltzman EM, Thom RR, Casnellie JE. Activation of a tyrosine protein kinase is an early event in the stimulation of T lymphocytes by interleukin-2. J Biol Chem 1988; 263: 6956-6959
  • 37 Merida I, Gaulton GN. Protein tyrosine phosphorylation associated with activation of theinterleukin 2 receptor. J Biol Chem 1990; 265: 5690-5694
  • 38 Petruzzelli L, Herrera R, Rosen OM. Insulin receptor is an insulin-dependent tyrosine kinase: Copurification of insulin-binding activity and protein kinase activity to homogeneity from human placenta. Proc Natl Acad Sci USA 1984; 81: 3327-31
  • 39 Yu K-T, Czech MP. Tyrosine phosphorylation of theinsulin receptor B subunit activates the receptor-associated tyrosine kinase activity. J Biol Chem 1984; 159: 5277-5286
  • 40 Frasier-Scott K, Hatzakis H, Seong D, Jones M, Wu KK. Influence of natural and recombinant interleukin 2 on endothelial cell arachidonate metabolism. J Clin Invest 1988; 82: 1877-1883
  • 41 Prins BA, Hu R-M, Nazario B, Pedram A, Frank HJL, Weber MA, Levin ER. E2Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. J Biol Chem 1994; 269: 11938-11944